Dr David Preiss

Honorary Clinical Senior Lecturer (School of Cardiovascular & Metabolic Health)

email: David.Preiss@glasgow.ac.uk

Import to contacts

https://orcid.org/0000-0003-3139-1836

Publications

List by: Type | Date

Jump to: 2023 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006

Number of items: 92.

2023

Mayne, K. J. et al. (2023) Effects of empagliflozin on fluid overload, weight and blood pressure in chronic kidney disease. Journal of the American Society of Nephrology, (doi: 10.1681/ASN.0000000000000271) (PMID:38082486) (Early Online Publication)

2020

Coll, A. P. et al. (2020) GDF15 mediates the effects of metformin on body weight and energy balance. Nature, 578, pp. 444-448. (doi: 10.1038/s41586-019-1911-y) (PMID:31875646) (PMCID:PMC7234839)

2019

Sattar, Naveed ORCID: https://orcid.org/0000-0002-1604-2593 and Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836 (2019) Research digest: new horizons in heart failure therapy. Lancet Diabetes and Endocrinology, 7(11), p. 832. (doi: 10.1016/S2213-8587(19)30315-8) (PMID:31621593)

Kristensen, Soren L., Rorth, Rasmus, Jhund, Pardeep S. ORCID: https://orcid.org/0000-0003-4306-5317, Docherty, Kieran ORCID: https://orcid.org/0000-0002-5446-9969, Sattar, Naveed ORCID: https://orcid.org/0000-0002-1604-2593, Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836, Kober, Lars, Petrie, Mark C. ORCID: https://orcid.org/0000-0002-6333-9496 and McMurray, John J.V. ORCID: https://orcid.org/0000-0002-6317-3975 (2019) Cardiovascular, mortality and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet Diabetes and Endocrinology, 7(10), pp. 776-785. (doi: 10.1016/S2213-8587(19)30249-9) (PMID:31422062)

Welsh, P. et al. (2019) Cardiac troponin T and troponin I in the general population: comparing and contrasting their genetic determinants and associations with outcomes. Circulation, 139(24), pp. 2754-2764. (doi: 10.1161/CIRCULATIONAHA.118.038529) (PMID:31014085) (PMCID:PMC6571179)

2018

Welsh, P. et al. (2018) Comparison between high-sensitivity cardiac troponin T and cardiac troponin I in a large general population cohort. Clinical Chemistry, 64(11), pp. 1607-1616. (doi: 10.1373/clinchem.2018.292086) (PMID:30126950)

2017

Sattar, Naveed ORCID: https://orcid.org/0000-0002-1604-2593, Toth, Peter P., Blom, Dirk J., Koren, Michael J., Soran, Handrean, Uhart, Magdalena, Elliott, Mary, Cyrille, Marcoli, Somaratne, Ransi and Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836 (2017) Effect of the proprotein convertase subtilisin/kexin type 9 inhibitor evolocumab on glycemia, body weight, and new-onset diabetes mellitus. American Journal of Cardiology, 120(9), pp. 1521-1527. (doi: 10.1016/j.amjcard.2017.07.047) (PMID:28844508)

Sattar, Naveed ORCID: https://orcid.org/0000-0002-1604-2593 and Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836 (2017) Reverse causality in cardiovascular epidemiological research: more common than imagined? Circulation, 135(24), pp. 2369-2372. (doi: 10.1161/CIRCULATIONAHA.117.028307) (PMID:28606949)

Toth, P. P. et al. (2017) Pooled safety analysis of evolocumab in over 6000 patients from double-blind and open-label extension studies. Circulation, 135(19), pp. 1819-1831. (doi: 10.1161/CIRCULATIONAHA.116.025233) (PMID:28249876)

Preiss, D. et al. (2017) Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes. Diabetes, Obesity and Metabolism, 19(3), pp. 356-363. (doi: 10.1111/dom.12826) (PMID:27862873) (PMCID:PMC5330429)

Schmidt, A. F. et al. (2017) PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study. Lancet Diabetes and Endocrinology, 5(2), pp. 97-105. (doi: 10.1016/S2213-8587(16)30396-5) (PMID:27908689) (PMCID:PMC5266795)

Kristensen, S. L. et al. (2017) Clinical and echocardiographic characteristics and cardiovascular outcomes according to diabetes status in patients with heart failure and preserved ejection fraction. A report from the Irbesartan in Heart Failure with Preserved Ejection Fraction Trial (I-Preserve). Circulation, 135(8), pp. 724-735. (doi: 10.1161/CIRCULATIONAHA.116.024593) (PMID:28052977)

2016

Preiss, D. ORCID: https://orcid.org/0000-0003-3139-1836, Rankin, N. ORCID: https://orcid.org/0000-0002-7566-1407, Welsh, P. ORCID: https://orcid.org/0000-0002-7970-3643, Holman, R.R., Kangas, A.J., Soininen, P., Würtz, P., Ala-Korpela, M. and Sattar, N. ORCID: https://orcid.org/0000-0002-1604-2593 (2016) Effect of metformin therapy on circulating amino acids in a randomized trial: the CAMERA study. Diabetic Medicine, 33(11), pp. 1569-1574. (doi: 10.1111/dme.13097) (PMID:26887663)

Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836 and Sattar, Naveed ORCID: https://orcid.org/0000-0002-1604-2593 (2016) Research digest: cardiac biomarkers for risk prediction. Lancet Diabetes and Endocrinology, 4(11), p. 890. (doi: 10.1016/S2213-8587(16)30293-5) (PMID:27743976)

Sattar, Naveed ORCID: https://orcid.org/0000-0002-1604-2593, Logue, Jennifer ORCID: https://orcid.org/0000-0001-9549-2738 and Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836 (2016) Research digest: weight loss to prevent and treat diabetes. Lancet Diabetes and Endocrinology, 4(10), p. 817. (doi: 10.1016/S2213-8587(16)30244-3) (PMID:27663958)

Currie, G. et al. (2016) Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis. BMC Nephrology, 17, 127. (doi: 10.1186/s12882-016-0337-0) (PMID:27609359) (PMCID:PMC5015203)

Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836 and Sattar, Naveed ORCID: https://orcid.org/0000-0002-1604-2593 (2016) Research digest: NAFLD in the spotlight. Lancet Diabetes and Endocrinology, 4(9), p. 735. (doi: 10.1016/S2213-8587(16)30187-5) (PMID:27480034)

Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836, Welsh, Paul ORCID: https://orcid.org/0000-0002-7970-3643 and Sattar, Naveed ORCID: https://orcid.org/0000-0002-1604-2593 (2016) Metformin therapy and circulating NT-proBNP levels: the CAMERA trial. Diabetes Care, 39(8), e114-e115. (doi: 10.2337/dc16-0887) (PMID:27271181)

Sattar, Naveed ORCID: https://orcid.org/0000-0002-1604-2593 and Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836 (2016) Research digest. Lancet Diabetes and Endocrinology, 4(8), p. 651. (doi: 10.1016/S2213-8587(16)30161-9) (PMID:27401823)

Sattar, Naveed ORCID: https://orcid.org/0000-0002-1604-2593, McLaren, James, Kristensen, Soren L., Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836 and McMurray, John J.V. ORCID: https://orcid.org/0000-0002-6317-3975 (2016) SGLT2 and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? Diabetologia, 59(7), pp. 1333-1339. (doi: 10.1007/s00125-016-3956-x) (PMID:27112340) (PMCID:PMC4901113)

Sattar, Naveed ORCID: https://orcid.org/0000-0002-1604-2593, McLaren, James, Kristensen, Søren L., Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836 and McMurray, John J. ORCID: https://orcid.org/0000-0002-6317-3975 (2016) Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? Diabetologia, 59(7), pp. 1573-1574. (doi: 10.1007/s00125-016-3987-3) (PMID:27174369) (PMCID:PMC4969788)

Sattar, Naveed ORCID: https://orcid.org/0000-0002-1604-2593 and Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836 (2016) Diabetic microvascular complications as simple indicators of risk for cardiovascular outcomes and heart failure. Lancet Diabetes and Endocrinology, 4(7), pp. 555-556. (doi: 10.1016/s2213-8587(16)30097-3) (PMID:27216887)

Sattar, Naveed ORCID: https://orcid.org/0000-0002-1604-2593 and Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836 (2016) Screening for diabetes in patients with cardiovascular disease: HbA1c trumps oral glucose tolerance testing. Lancet Diabetes and Endocrinology, 4(7), pp. 560-562. (doi: 10.1016/S2213-8587(16)00085-1) (PMID:27039357)

Nissen, S. E. et al. (2016) Efficacy and tolerability of evolocumab vs. ezetimibe in patients with muscle-related statin intolerance: the GAUSS-3 randomized clinical trial. JAMA: Journal of the American Medical Association, 315(15), pp. 1580-1590. (doi: 10.1001/jama.2016.3608) (PMID:27039291)

Loomis, A. K. et al. (2016) Body mass index and risk of non-alcoholic fatty liver disease: two electronic health record prospective studies. Journal of Clinical Endocrinology and Metabolism, 101(3), pp. 945-952. (doi: 10.1210/jc.2015-3444) (PMID:26672639) (PMCID:PMC4803162)

Goldie, Christina, Taylor, Allen J., Nguyen, Peter, McCoy, Cody, Zhao, Xue-Qiao and Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836 (2016) Niacin therapy and the risk of new-onset diabetes: a meta-analysis of randomized controlled trials. Heart, 102(3), pp. 198-203. (doi: 10.1136/heartjnl-2015-308055) (PMID:26370223)

Welsh, P. et al. (2016) Prediction of cardiovascular disease risk by cardiac biomarkers in 2 United Kingdom cohort studies: does utility depend on risk thresholds for treatment? Hypertension, 2016(67), pp. 309-315. (doi: 10.1161/HYPERTENSIONAHA.115.06501) (PMID:26667414) (PMCID:PMC4716288)

Kristensen, S. L. et al. (2016) Risk related to pre–diabetes mellitus and diabetes mellitus in heart failure with reduced ejection fraction: insights from prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial. Circulation: Heart Failure, 9(1), e002560. (doi: 10.1161/CIRCHEARTFAILURE.115.002560) (PMID:26754626) (PMCID:PMC4718182)

Jackson, C. E. et al. (2016) The incremental prognostic and clinical value of multiple novel biomarkers in heart failure. European Journal of Heart Failure, 18(12), pp. 1491-1498. (doi: 10.1002/ejhf.543) (PMID:27114189)

Rankin, Naomi J. ORCID: https://orcid.org/0000-0002-7566-1407, Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836, Welsh, Paul ORCID: https://orcid.org/0000-0002-7970-3643 and Sattar, Naveed ORCID: https://orcid.org/0000-0002-1604-2593 (2016) Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future. International Journal of Epidemiology, 45(5), pp. 1351-1371. (doi: 10.1093/ije/dyw271) (PMID:27789671) (PMCID:PMC5100629)

Sattar, Naveed ORCID: https://orcid.org/0000-0002-1604-2593, Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836, Robinson, Jennifer G., Djedjos, C. Stephen, Elliott, Mary, Somaratne, Ransi, Wasserman, Scott M. and Raal, Frederick J. (2016) Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab in patients with type 2 diabetes: a meta-analysis. Lancet Diabetes and Endocrinology, 4(5), pp. 403-410. (doi: 10.1016/S2213-8587(16)00003-6) (PMID:26868195)

2015

Jackson, C. E. et al. (2015) Combined free light chains are novel predictors of prognosis in heart failure. JACC: Heart Failure, 3(8), pp. 618-625. (doi: 10.1016/j.jchf.2015.03.014) (PMID:26251088)

Preiss, D. et al. (2015) Prospective relationships between body weight and physical activity: an observational analysis from the NAVIGATOR study. BMJ Open, 5(8), e007901. (doi: 10.1136/bmjopen-2015-007901) (PMID:26275900) (PMCID:PMC4550730)

Rush, Christopher J., Campbell, Ross T. ORCID: https://orcid.org/0000-0002-0050-2129, Jhund, Pardeep S. ORCID: https://orcid.org/0000-0003-4306-5317, Connolly, Eugene C., Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836, Gardner, Roy S., Petrie, Mark C. ORCID: https://orcid.org/0000-0002-6333-9496 and McMurray, John J.V. ORCID: https://orcid.org/0000-0002-6317-3975 (2015) Falling cardiovascular mortality in heart failure with reduced ejection fraction and implications for clinical trials. JACC: Heart Failure, 3(8), pp. 603-614. (doi: 10.1016/j.jchf.2015.03.013) (PMID:26251086)

Yates, T. et al. (2015) Physical activity as a determinant of fasting and 2-h post-challenge glucose: a prospective cohort analysis of the NAVIGATOR trial. Diabetic Medicine, 32(8), pp. 1090-1096. (doi: 10.1111/dme.12762) (PMID:25818859)

Preiss, D. et al. (2015) The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials. European Heart Journal, 36(24), pp. 1536-1546. (doi: 10.1093/eurheartj/ehv072) (PMID:25802390) (PMCID:PMC4769322)

Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836 and Kristensen, Søren L. (2015) The new Pooled cohort equations risk calculator. Canadian Journal of Cardiology, 31(5), pp. 613-619. (doi: 10.1016/j.cjca.2015.02.001) (PMID:25843167)

Kristensen, S. L. et al. (2015) Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction. European Journal of Heart Failure, 17(2), pp. 169-176. (doi: 10.1002/ejhf.211) (PMID:25756844)

Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836 and Sattar, Naveed ORCID: https://orcid.org/0000-0002-1604-2593 (2015) Classification of reported statin intolerance. Current Opinion in Lipidology, 26(1), pp. 65-66. (doi: 10.1097/MOL.0000000000000149) (PMID:25551804)

Swerdlow, D. I. et al. (2015) HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet, 385(9965), pp. 351-361. (doi: 10.1016/S0140-6736(14)61183-1) (PMID:25262344) (PMCID:PMC4322187)

Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836 and Sattar, Naveed ORCID: https://orcid.org/0000-0002-1604-2593 (2015) Does the LDL receptor play a role in the risk of developing type 2 diabetes? JAMA: Journal of the American Medical Association, 313(10), pp. 1016-1017. (doi: 10.1001/jama.2015.1275) (PMID:25756436)

Sattar, Naveed ORCID: https://orcid.org/0000-0002-1604-2593, Welsh, Paul ORCID: https://orcid.org/0000-0002-7970-3643 and Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836 (2015) The insulin resistance syndrome. In: DeFronzo, Ralph A., Ferrannini, Eleuterio, Alberti, K.G.M.M. and Zimmet, Paul (eds.) International Textbook of Diabetes Mellitus. John Wiley & Sons, Ltd, pp. 337-353. ISBN 9781118387658 (doi: 10.1002/9781118387658.ch23)

Welsh, Paul ORCID: https://orcid.org/0000-0002-7970-3643, Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836 and Touyz, Rhian M. ORCID: https://orcid.org/0000-0003-0670-0887 (2015) Biomarkers of hypertension and cardiovascular disease. In: Peplow, Philip, Adams, James and Young, Tim (eds.) Cardiovascular and Metabolic Disease: Scientific Discoveries and New Therapies. Series: RSC Drug discovery series. Royal Society of Chemistry, pp. 117-136. ISBN 9781782620464 (doi: 10.1039/9781782622390-00117)

Welsh, Paul ORCID: https://orcid.org/0000-0002-7970-3643, Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836, Tsiropoulou, Sofia, Rios, Francisco J. ORCID: https://orcid.org/0000-0002-8194-0787, Harvey, Adam, Dulak-Lis, Maria G., Montezano, Augusto C. and Touyz, Rhian M. ORCID: https://orcid.org/0000-0003-0670-0887 (2015) Biomarkers of vascular inflammation and cardiovascular disease. In: Berbari, Adel and Mancia, Giuseppe (eds.) Arterial Disorders: Definition, Clinical Manifestations, Mechanisms and Therapeutic Approaches. Springer: Cham, pp. 115-136. ISBN 9783319145556 (doi: 10.1007/978-3-319-14556-3_9)

2014

Preiss, D. et al. (2014) Change in levels of physical activity after diagnosis of type 2 diabetes: an observational analysis from the NAVIGATOR study. Diabetes, Obesity and Metabolism, 16(12), pp. 1265-1268. (doi: 10.1111/dom.12320) (PMID:24861892)

Welsh, P. et al. (2014) Contrasting associations of insulin resistance with diabetes, cardiovascular disease and all-cause mortality in the elderly: PROSPER long-term follow-up. Diabetologia, 57(12), pp. 2513-2520. (doi: 10.1007/s00125-014-3383-9) (PMID:25264116)

Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836 (2014) Do statins reduce microvascular complications in diabetes? Lancet Diabetes and Endocrinology, 2(11), pp. 858-859. (doi: 10.1016/S2213-8587(14)70177-9) (PMID:25217179)

Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836, McMurray, John J. ORCID: https://orcid.org/0000-0002-6317-3975 and Sattar, Naveed ORCID: https://orcid.org/0000-0002-1604-2593 (2014) Treatment of severe hypertriglyceridaemia. Lancet Diabetes and Endocrinology, 2(11), p. 860. (doi: 10.1016/s2213-8587(14)70052-x) (PMID:25439459)

Rankin, Naomi J. ORCID: https://orcid.org/0000-0002-7566-1407, Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836, Welsh, Paul ORCID: https://orcid.org/0000-0002-7970-3643, Burgess, Karl E.V., Nelson, Scott M. ORCID: https://orcid.org/0000-0002-9099-3047, Lawlor, Debbie A. and Sattar, Naveed ORCID: https://orcid.org/0000-0002-1604-2593 (2014) The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspective. Atherosclerosis, 237(1), pp. 287-300. (doi: 10.1016/j.atherosclerosis.2014.09.024) (PMID:25299963) (PMCID:PMC4232363)

Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836 and Packard, Chris J. ORCID: https://orcid.org/0000-0002-2386-9927 (2014) Emerging therapeutic approaches to treat dyslipidemia. Current Cardiology Reports, 16(7), (doi: 10.1007/s11886-014-0506-3) (PMID:24890766)

Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836, Lloyd, Suzanne M. ORCID: https://orcid.org/0000-0003-4405-0846, Ford, Ian ORCID: https://orcid.org/0000-0001-5927-1823, McMurray, John J.V. ORCID: https://orcid.org/0000-0002-6317-3975, Holman, Rury R., Welsh, Paul ORCID: https://orcid.org/0000-0002-7970-3643, Fisher, Miles, Packard, Chris J. ORCID: https://orcid.org/0000-0002-2386-9927 and Sattar, Naveed ORCID: https://orcid.org/0000-0002-1604-2593 (2014) Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. Lancet Diabetes and Endocrinology, 2(2), pp. 116-124. (doi: 10.1016/S2213-8587(13)70152-9) (PMID:24622715)

Sattar, Naveed ORCID: https://orcid.org/0000-0002-1604-2593, Forrest, Ewan and Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836 (2014) Non-alcoholic fatty liver disease. British Medical Journal, 2014(349), g4596. (doi: 10.1136/bmj.g4596) (PMID:25239614) (PMCID:PMC4168663)

2013

Preiss, D. ORCID: https://orcid.org/0000-0003-3139-1836 and Sattar, N. ORCID: https://orcid.org/0000-0002-1604-2593 (2013) Choice of medical therapy to lower triglycerides in those at risk of pancreatitis. Current Opinion in Lipidology, 24(6), pp. 532-533. (doi: 10.1097/MOL.0000000000000029)

Perez, A.C., Jhund, P. ORCID: https://orcid.org/0000-0003-4306-5317, Preiss, D. ORCID: https://orcid.org/0000-0003-3139-1836, Kjekshus, J. and McMurray, J.J.V. ORCID: https://orcid.org/0000-0002-6317-3975 (2013) Effect of rosuvastatin on fatigue in patients with heart failure. Journal of the American College of Cardiology, 61(10), pp. 1121-1122. (doi: 10.1016/j.jacc.2012.12.004)

Preiss, D. ORCID: https://orcid.org/0000-0003-3139-1836 (2013) Triglyceride levels, pancreatitis and choice of lipid-modifying therapy. Expert Review of Gastroenterology and Hepatology, 7(3), pp. 193-195. (doi: 10.1586/EGH.12.79)

Preiss, D. et al. (2013) Predictors of stroke in patients with impaired glucose tolerance: results from the nateglinide and valsartan in impaired glucose tolerance outcomes research trial. Stroke, 44(9), pp. 2590-2593. (doi: 10.1161/STROKEAHA.113.001177)

2012

Preiss, D. et al. (2012) Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the nateglinide and valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial. BMJ Open, 2(6), e001925. (doi: 10.1136/bmjopen-2012-001925)

Preiss, D. et al. (2012) Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. JAMA: Journal of the American Medical Association, 308(8), pp. 804-811. (doi: 10.1001/jama.2012.8439)

Preiss, D. ORCID: https://orcid.org/0000-0003-3139-1836 (2012) Statin therapy and new-onset diabetes: a cause for concern? Maturitas, 72(2), pp. 95-96. (doi: 10.1016/j.maturitas.2012.02.014)

Preiss, D. ORCID: https://orcid.org/0000-0003-3139-1836 and Sattar, N. ORCID: https://orcid.org/0000-0002-1604-2593 (2012) Pharmacotherapy: statins and new-onset diabetes—the important questions. Nature Reviews Cardiology, 9(4), pp. 190-192. (doi: 10.1038/nrcardio.2012.15)

Preiss, D. et al. (2012) Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF). European Journal of Heart Failure, 14(8), pp. 909-915. (doi: 10.1093/eurjhf/hfs067)

Sattar, N. ORCID: https://orcid.org/0000-0002-1604-2593 and Preiss, D. ORCID: https://orcid.org/0000-0003-3139-1836 (2012) HbA_1c in type 2 diabetes diagnostic criteria: addressing the right questions to move the field forwards. Diabetologia, 55(6), pp. 1564-1567. (doi: 10.1007/s00125-012-2510-8)

2011

Ford, I. et al. (2011) The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes. International Journal of Epidemiology, 40(6), pp. 1530-1538. (doi: 10.1093/ije/dyr172)

Shyangdan, D., Clar, C., Ghouri, N. ORCID: https://orcid.org/0000-0002-8263-2591, Henderson, R., Gurung, T., Preiss, D. ORCID: https://orcid.org/0000-0003-3139-1836, Sattar, N. ORCID: https://orcid.org/0000-0002-1604-2593, Fraser, A. and Waugh, N. (2011) Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review. Health Technology Assessment, 15(38), pp. 1-110. (doi: 10.3310/hta15380)

Preiss, D. ORCID: https://orcid.org/0000-0003-3139-1836, Sesashai, S.R.K. and Ray, K.K. (2011) Statin therapy dose and risk of new-onset diabetes: reply. JAMA: Journal of the American Medical Association, 306(12), p. 1326. (doi: 10.1001/jama.2011.1355)

Preiss, D. ORCID: https://orcid.org/0000-0003-3139-1836 and Ray, K.K. (2011) Intensive glucose lowering treatment in type 2 diabetes. British Medical Journal, 343, d4243. (doi: 10.1136/bmj.d4243)

Ghouri, Nazim A. ORCID: https://orcid.org/0000-0002-8263-2591, Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836 and Sattar, Naveed ORCID: https://orcid.org/0000-0002-1604-2593 (2011) Reply (Need for a Three-Focused Approach to Nonalcoholic Fatty Liver Disease). Hepatology, 53(5), p. 1774. (doi: 10.1002/hep.24138)

Preiss, D. ORCID: https://orcid.org/0000-0003-3139-1836, Khunti, K. and Sattar, N. ORCID: https://orcid.org/0000-0002-1604-2593 (2011) Combined cardiovascular and diabetes risk assessment in primary care. Diabetic Medicine, 28(1), pp. 19-22. (doi: 10.1111/j.1464-5491.2010.03157.x)

Preiss, D. ORCID: https://orcid.org/0000-0003-3139-1836 and Sattar, N. ORCID: https://orcid.org/0000-0002-1604-2593 (2011) The case for diabetes screening: ADDITION-Europe. Lancet, 378(9786), pp. 106-108. (doi: 10.1016/S0140-6736(11)60819-2)

Preiss, D. ORCID: https://orcid.org/0000-0003-3139-1836 and Sattar, N. ORCID: https://orcid.org/0000-0002-1604-2593 (2011) Statins and the risk of new-onset diabetes: a review of recent evidence. Current Opinion in Lipidology, 22(6), pp. 460-466. (doi: 10.1097/MOL.0b013e32834b4994)

Preiss, D. ORCID: https://orcid.org/0000-0003-3139-1836, Sattar, N. ORCID: https://orcid.org/0000-0002-1604-2593 and McMurray, J.J. ORCID: https://orcid.org/0000-0002-6317-3975 (2011) A systematic review of event rates in clinical trials in diabetes mellitus: The importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design. American Heart Journal, 161(1), p. 210. (doi: 10.1016/j.ahj.2010.10.019)

Preiss, D. et al. (2011) Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA: Journal of the American Medical Association, 305(24), pp. 2556-2564. (doi: 10.1001/jama.2011.860)

2010

Sattar, N. et al. (2010) Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet, 375(9716), pp. 735-742. (doi: 10.1016/S0140-6736(09)61965-6)

Preiss, D. ORCID: https://orcid.org/0000-0003-3139-1836, Sattar, N. ORCID: https://orcid.org/0000-0002-1604-2593 and McMurray, J.J. ORCID: https://orcid.org/0000-0002-6317-3975 (2010) Event rates in trials of patients with Type 2 diabetes. JAMA: Journal of the American Medical Association, 303(8), pp. 732-733. (doi: 10.1001/jama.2010.137)

Ghouri, N. ORCID: https://orcid.org/0000-0002-8263-2591, Preiss, D. ORCID: https://orcid.org/0000-0003-3139-1836 and Sattar, N. ORCID: https://orcid.org/0000-0002-1604-2593 (2010) Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: A narrative review and clinical perspective of prospective data. Hepatology, 52(3), pp. 1156-1161. (doi: 10.1002/hep.23789)

Preiss, D. ORCID: https://orcid.org/0000-0003-3139-1836 and Sattar, N. ORCID: https://orcid.org/0000-0002-1604-2593 (2010) HbA1c: a useful cardiovascular risk marker in those without diabetes? Diabetologia, 53(12), pp. 2468-2469. (doi: 10.1007/s00125-010-1902-x)

Preiss, D. ORCID: https://orcid.org/0000-0003-3139-1836, Welsh, P. ORCID: https://orcid.org/0000-0002-7970-3643, Murray, H., Shepherd, J., Packard, C. ORCID: https://orcid.org/0000-0002-2386-9927, Macfarlane, P., Cobbe, S., Ford, I. ORCID: https://orcid.org/0000-0001-5927-1823 and Sattar, N. ORCID: https://orcid.org/0000-0002-1604-2593 (2010) Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up(dagger). European Heart Journal, 31(10), pp. 1230-1236. (doi: 10.1093/eurheartj/ehq095)

Sattar, N. ORCID: https://orcid.org/0000-0002-1604-2593, Preiss, D. ORCID: https://orcid.org/0000-0003-3139-1836, Welsh, P. ORCID: https://orcid.org/0000-0002-7970-3643, Seshasai, S.R.K. and Ray, K.K. (2010) Statins and risk of incident diabetes Reply. Lancet, 375(9732), pp. 2141-2142.

2009

Preiss, D. et al. (2009) Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Diabetes Care, 32(5), pp. 915-920. (doi: 10.2337/dc08-1709) (PMID:19196892)

Preiss, D.J. ORCID: https://orcid.org/0000-0003-3139-1836 and Sattar, N.A. ORCID: https://orcid.org/0000-0002-1604-2593 (2009) Metformin and lactic acidosis Metformin: framed again? British Medical Journal, 339, b5570. (doi: 10.1136/bmj.b5570)

Preiss, DJ ORCID: https://orcid.org/0000-0003-3139-1836 and Sattar, NA ORCID: https://orcid.org/0000-0002-1604-2593 (2009) Authors' reply to: Statin therapy as the fundamental therapy for cardiovascular prevention: be careful. Clinical Endocrinology, 71(3), pp. 456-457.

Preiss, DJ ORCID: https://orcid.org/0000-0003-3139-1836 and Sattar, NA ORCID: https://orcid.org/0000-0002-1604-2593 (2009) Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence. Clinical Endocrinology, 70(6), pp. 815-828.

Preiss, DJ ORCID: https://orcid.org/0000-0003-3139-1836 and Sattar, NA ORCID: https://orcid.org/0000-0002-1604-2593 (2009) Metabolic syndrome: collapsing under its own weight? Diabetic Medicine, 26(5), pp. 457-459.

Preiss, D. et al. (2009) Predictors of Development in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Diabetes Care, 32(5), pp. 915-920.

Ray, KK, Seshasai, SRK, Wijesuriya, S, Sivakumaran, R, Nethercott, S, Preiss, DJ ORCID: https://orcid.org/0000-0003-3139-1836, Erqou, S and Sattar, NA ORCID: https://orcid.org/0000-0002-1604-2593 (2009) Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet, 373(9677), pp. 1765-1772. (doi: 10.1016/S0140-6736(09)60697-8)

2008

Preiss, D. ORCID: https://orcid.org/0000-0003-3139-1836, Sattar, N. ORCID: https://orcid.org/0000-0002-1604-2593, Harborne, L., Norman, J.E. and Fleming, R. (2008) The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome. International Journal of Clinical Practice, 62(9), pp. 1337-1343. (doi: 10.1111/j.1742-1241.2008.01825.x)

Preiss, D. ORCID: https://orcid.org/0000-0003-3139-1836, Todd, L. and Panarelli, M. (2008) Diagnosing unsuspected hypopituitarism in adults from suggestive thyroid function test results. Annals of Clinical Biochemistry, 45(1), pp. 70-75. (doi: 10.1258/acb.2007.007100)

Preiss, DJ ORCID: https://orcid.org/0000-0003-3139-1836 and Sattar, NA ORCID: https://orcid.org/0000-0002-1604-2593 (2008) Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clinical Science, 115(5-6), pp. 141-150.

2007

Preiss, D.J. ORCID: https://orcid.org/0000-0003-3139-1836, Godber, I.M., Lamb, E.J., Dalton, R.N. and Gunn, I.R. (2007) The influence of a cooked-meat meal on estimated glomerular filtration rate. Annals of Clinical Biochemistry, 44(1), pp. 35-42. (doi: 10.1258/000456307779595995)

Preiss, D.J. ORCID: https://orcid.org/0000-0003-3139-1836 and Sattar, N. ORCID: https://orcid.org/0000-0002-1604-2593 (2007) Vascular cell adhesion molecule-1: a viable therapeutic target for atherosclerosis? International Journal of Clinical Practice, 61(4), pp. 697-701. (doi: 10.1111/j.1742-1241.2007.01330.x)

2006

Preiss, D. ORCID: https://orcid.org/0000-0003-3139-1836 and Sattar, N. ORCID: https://orcid.org/0000-0002-1604-2593 (2006) Metabolic syndrome, dysglycaemia and vascular disease: making sense of the evidence. Heart, 93(12), pp. 1493-1496. (doi: 10.1136/hrt.2007.130849)

Preiss, D.J. ORCID: https://orcid.org/0000-0003-3139-1836, Godber, I.M. and Gunn, I.R. (2006) How to measure renal function in clinical practice: Eating cooked meat alters serum creatinine concentration and eGFR significantly. British Medical Journal, 333(7577), p. 1072. (doi: 10.1136/bmj.39030.730949.3A)

This list was generated on Mon Jun 30 00:15:06 2025 BST.

Jump to: Articles | Book Sections